- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07765771
Minimal-Incision Technique With Modified Tracking Pin Placement Versus Standard Robotic-Assisted Total Knee Arthroplasty (MISI)
Comparison of a Minimal Incision and Minimal Soft-Tissue Injury (MISI) Technique Versus the Standard Technique in Robotic-Assisted Total Knee Arthroplasty: A Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
Robotic-assisted total knee arthroplasty requires surgical exposure and placement of tracking pins. Conventional techniques may involve a relatively long incision, broader soft-tissue dissection, and diaphyseal pin insertion. The MISI technique was developed to reduce surgical invasiveness through a shorter incision, limited soft-tissue dissection, and modified tracking pin placement that avoids diaphyseal pin insertion.
Participants will be randomly assigned to the MISI or standard technique in a 1:1 ratio. Clinical evaluations will be performed during follow-up for up to 12 months. The study will assess whether the MISI technique improves scar-related outcomes and early recovery without increasing procedure-related complications.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ho-Jung Jung, MD, PhD
- Phone Number: 82-02-819-5165
- Email: hodge@hallym.or.kr
Study Locations
-
-
-
Seoul, South Korea
- Hallym University Kangnam Sacred Heart Hospital
-
Contact:
- Ho-Jung Jung, MD, PhD
- Phone Number: 82-02-819-5165
- Email: hodge@hallym.or.kr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 years or older
- Degenerative knee osteoarthritis requiring robotic-assisted total knee arthroplasty
- Body mass index below 30 kg/m²
- Preoperative knee flexion of 90 degrees or greater
- Ability to understand the study information and provide written informed consent
Exclusion Criteria:
- Skin lesions or conditions that may adversely affect wound healing
- Previous intra-articular surgery of the affected knee
- Inflammatory arthritis, including rheumatoid arthritis
- Severe hepatic or renal disease associated with poor general health
- Comorbid conditions that may substantially affect mobility, including Parkinson disease, sequelae of poliomyelitis, or stroke
- Inability or unwillingness to complete the required follow-up
- Any medical or other condition that, in the investigator's judgment, makes participation inappropriate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MISI tenchique
Participants will undergo robotic-assisted total knee arthroplasty using the minimal incision and minimal soft-tissue injury (MISI) technique.
The procedure uses an approximately 10-cm main incision with limited soft-tissue dissection.
Two femoral tracking pins are inserted through the main incision, and one tibial tracking pin is inserted through an additional approximately 5-mm incision.
|
Robot-assisted total knee arthroplasty performed using an approximately 10-cm main incision, limited soft-tissue dissection, two femoral tracking pins inserted through the main incision, and one tibial tracking pin inserted through an additional approximately 5-mm incision.
|
|
Active Comparator: Standard technique
Participants will undergo robotic-assisted total knee arthroplasty using the standard surgical technique.
Tracking arrays are secured using the conventional pin placement method, with four tracking pins placed in the femoral and tibial regions and an additional femoral incision.
|
Robot-assisted total knee arthroplasty performed using the standard incision and soft-tissue exposure, with conventional placement of four tracking pins in the femoral and tibial regions and an additional femoral incision.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient and Observer Scar Assessment Scale Score
Time Frame: 3 months after surgery
|
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score.
Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120.
Higher scores indicate poorer scar quality.
The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
|
3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient and Observer Scar Assessment Scale Score
Time Frame: 3 and 6 weeks after surgery
|
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score.
Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120.
Higher scores indicate poorer scar quality.
The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
|
3 and 6 weeks after surgery
|
|
Main Surgical Incision Length
Time Frame: During surgery and on postoperative day 1
|
The length of the main surgical incision will be measured in centimeters.
The initial incision length will be measured immediately after the skin incision with the knee in extension, and the final incision length will be measured before wound closure.
The incision length will also be evaluated on postoperative day 1.
Separate tracking pin-site incisions will not be included.
|
During surgery and on postoperative day 1
|
|
Intraoperative Incision Stretching Index
Time Frame: During surgery
|
The incision stretching index is calculated as the maximum length of the main incision during knee flexion and maximal surgical retraction divided by the initial incision length measured with the knee in extension.
A value of 1 indicates no stretching, and higher values indicate greater intraoperative stretching of the incision and surrounding soft tissue.
|
During surgery
|
|
Postoperative Gauze Oozing Grade
Time Frame: Postoperative days 1, 2, 4, and 6
|
Postoperative wound oozing will be assessed according to the amount of blood or exudate visible on the surgical dressing using a prespecified ordinal grading scale.
Higher grades indicate more extensive wound oozing.
|
Postoperative days 1, 2, 4, and 6
|
|
Thigh Pain at Rest on the Numeric Rating Scale
Time Frame: Postoperative days 1, 2, 4, and 6
|
Participants will rate thigh pain at rest using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Thigh Pain During Active Hip Flexion on the Numeric Rating Scale
Time Frame: Postoperative days 1, 2, 4, and 6
|
Participants will rate thigh pain during active hip flexion while maintaining knee extension and without external resistance.
Pain will be assessed using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Tenderness at the Standardized Tracking Pin-Site Location
Time Frame: Postoperative days 1, 2, 4, and 6
|
Tenderness elicited by palpation at a prespecified standardized anatomical location corresponding to the tracking pin region will be rated using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no tenderness and 10 indicates the worst imaginable tenderness.
|
Postoperative days 1, 2, 4, and 6
|
|
Ability to Perform Straight-Leg Raising
Time Frame: Postoperative days 1, 2, 4, and 6
|
The participant's ability to independently raise the operated lower extremity while maintaining knee extension will be recorded as a binary outcome: able or unable to perform straight-leg raising.
The number and proportion of participants able to perform the test will be compared between groups.
|
Postoperative days 1, 2, 4, and 6
|
|
Pain During the Resisted Straight-Leg-Raising Test
Time Frame: Postoperative days 1, 2, 4, and 6
|
Pain during resisted straight-leg raising will be assessed using a 100-mm visual analog scale, where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Incidence of Tracking Pin-Site Complications
Time Frame: Postoperative days 1, 2, 4, and 6 and postoperative week 3
|
Tracking pin sites will be examined for complications, including erythema, swelling, wound drainage, infection, and pin-related fracture.
The occurrence of one or more prespecified pin-site complications will be recorded as a binary outcome, and the number and proportion of participants with any complication will be reported.
|
Postoperative days 1, 2, 4, and 6 and postoperative week 3
|
|
Forgotten Joint Score-12
Time Frame: 6 and 12 months after surgery
|
The Forgotten Joint Score-12 is a 12-item patient-reported questionnaire assessing awareness of the operated knee during daily activities.
Scores are transformed to a scale ranging from 0 to 100, with higher scores indicating less awareness of the artificial joint and a better outcome.
|
6 and 12 months after surgery
|
|
Western Ontario and McMaster Universities Osteoarthritis Index
Time Frame: 6 and 12 months after surgery
|
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) assesses knee pain, stiffness, and physical function.
The 24 items are scored using a 5-point Likert scale, producing a total score ranging from 0 to 96.
Higher scores indicate more severe symptoms and poorer physical function.
|
6 and 12 months after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Joong-Il Kim, MD, PhD, Hallym University Kangnam Sacred Heart Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HKS 2026-05-024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.